Literature DB >> 19032917

Atrial fibrillation in heart failure: current treatment of patients with remodeled atria.

Hans-Ruprecht Neuberger1, Jan-Christian Reil, Oliver Adam, Ulrich Laufs, Christian Mewis, Michael Böhm.   

Abstract

Atrial fibrillation (AF) and chronic heart failure (CHF) can be caused by each other, and therefore constitute a vicious circle. The prevalence of both conditions is about 1% in industrialized countries and increases with age. Although mortality is increased in heart failure, the additional prognostic relevance of AF in these patients is less clear. AF in patients with CHF can worsen heart failure symptoms, cause complications (eg, stroke), and is difficult to treat. Thus, prevention of AF entirely is an important goal. This review summarizes recent data concerning prognostic relevance, treatment, and means of primary and secondary prevention of AF in patients with CHF.

Entities:  

Mesh:

Year:  2008        PMID: 19032917     DOI: 10.1007/s11897-008-0033-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  58 in total

1.  Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry.

Authors:  Gaetano M De Ferrari; Catherine Klersy; Paolo Ferrero; Cecilia Fantoni; Diego Salerno-Uriarte; Lorenzo Manca; Paolo Devecchi; Giulio Molon; Miriam Revera; Antonio Curnis; Simona Sarzi Braga; Francesco Accardi; Jorge A Salerno-Uriarte
Journal:  Eur J Heart Fail       Date:  2006-12-14       Impact factor: 15.534

Review 2.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

3.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

4.  Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation.

Authors:  Julio A Chirinos; Aurelio Castrellon; Juan Pablo Zambrano; Joaquin J Jimenez; Wenche Jy; Lawrence L Horstman; Howard J Willens; Agustin Castellanos; Robert J Myerburg; Yeon S Ahn
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

5.  ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.

Authors:  A Boldt; A Scholl; J Garbade; M E Resetar; F W Mohr; J F Gummert; St Dhein
Journal:  Basic Res Cardiol       Date:  2005-12-29       Impact factor: 17.165

6.  Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.

Authors:  Peter Paul H M Delnoy; Jan Paul Ottervanger; Henk Oude Luttikhuis; Arif Elvan; Anand R Ramdat Misier; Willem P Beukema; Norbert M van Hemel
Journal:  Am J Cardiol       Date:  2007-03-13       Impact factor: 2.778

7.  Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?

Authors:  Iwan C C van der Horst; Adriaan A Voors; Dirk J van Veldhuisen
Journal:  Clin Res Cardiol       Date:  2007-02-15       Impact factor: 5.460

8.  Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data.

Authors:  K Gjesdal; J Feyzi; S B Olsson
Journal:  Heart       Date:  2007-05-04       Impact factor: 5.994

9.  Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.

Authors:  Tadashi Fujino; Takeshi Yamashita; Shinya Suzuki; Hiroaki Sugiyma; Koichi Sagara; Hitoshi Sawada; Tadanori Aizawa; Masaki Igarashi; Junichi Yamazaki
Journal:  Circ J       Date:  2007-06       Impact factor: 2.993

10.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; Marco Metra; François Regoli; Cecilia Fantoni; Barbara Lamp; Antonio Curnis; Juergen Vogt; Catherine Klersy
Journal:  Eur Heart J       Date:  2008-04-04       Impact factor: 29.983

View more
  2 in total

1.  Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease.

Authors:  Ilker Murat Caglar; Tolga Dasli; Fatma Nihan Turhan Caglar; Mehmet Kamil Teber; Murat Ugurlucan; Gokhan Ozmen
Journal:  Clin Res Cardiol       Date:  2012-03-06       Impact factor: 5.460

2.  Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.

Authors:  Emmanouil Chourdakis; Ioanna Koniari; Dimitrios Velissaris; Grigorios Tsigkas; Nikolaos G Kounis; Neriman Osman
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.